123 related articles for article (PubMed ID: 36337064)
1. Epigenteic Alteration of
Moradi A; Aleyasin SA; Mohammadian K; Alizamir A
Iran J Biotechnol; 2022 Apr; 20(2):e3050. PubMed ID: 36337064
[TBL] [Abstract][Full Text] [Related]
2. Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer.
Aleyasin SA; Moradi A; Abolhasani N; Abdollahi M
Mol Biol Rep; 2024 Feb; 51(1):253. PubMed ID: 38302798
[TBL] [Abstract][Full Text] [Related]
3. DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired tamoxifen resistant in breast cancer.
Gowdini E; Aleyasin SA; Ramezani N; Nafisi N; Tutuni M
J Hum Genet; 2023 Jan; 68(1):33-38. PubMed ID: 36372800
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia.
Lin R; Li C; Liu Z; Wu R; Lu J
J Transl Med; 2020 Jul; 18(1):292. PubMed ID: 32736574
[TBL] [Abstract][Full Text] [Related]
5. Alteration in Methylation Pattern of Retinoblastoma 1 Gene Promotor Region in Intestinal Metaplasia with or without Helicobacter pylori and Gastric Cancer Patients.
Boyacioglu SO; Kasap E; Yuceyar H; Korkmaz M
Adv Clin Exp Med; 2016; 25(3):465-70. PubMed ID: 27629734
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.
To KF; Leung WK; Lee TL; Yu J; Tong JH; Chan MW; Ng EK; Chung SC; Sung JJ
Int J Cancer; 2002 Dec; 102(6):623-8. PubMed ID: 12448005
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
8. CpG island hypermethylation in gastric carcinoma and its premalignant lesions.
Kang GH
Korean J Pathol; 2012 Feb; 46(1):1-9. PubMed ID: 23109971
[TBL] [Abstract][Full Text] [Related]
9. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
Krishnan V; Lim DXE; Hoang PM; Srivastava S; Matsuo J; Huang KK; Zhu F; Ho KY; So JBY; Khor C; Tsao S; Teh M; Fock KM; Ang TL; Jeyasekharan AD; Tan P; Yeoh KG; Ito Y
Gut; 2020 Oct; 69(10):1738-1749. PubMed ID: 31937549
[TBL] [Abstract][Full Text] [Related]
10. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
[TBL] [Abstract][Full Text] [Related]
11. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.
Kang GH; Lee HJ; Hwang KS; Lee S; Kim JH; Kim JS
Am J Pathol; 2003 Oct; 163(4):1551-6. PubMed ID: 14507661
[TBL] [Abstract][Full Text] [Related]
12. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
13. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
[TBL] [Abstract][Full Text] [Related]
14. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
15. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT
Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707
[TBL] [Abstract][Full Text] [Related]
16. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
17. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
Niu H; Jia Y; Li T; Su B
Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands.
Sugimoto R; Habano W; Yanagawa N; Akasaka R; Toya Y; Sasaki A; Matsumoto T; Sugai T
Gastric Cancer; 2021 Mar; 24(2):382-391. PubMed ID: 33141339
[TBL] [Abstract][Full Text] [Related]
19. Gastric intestinal metaplasia: Long-term follow-up results.
Rakici H; Uyanik E; Rakici IM; Polat HB; Akdogan RA; Aydin G; Ayvaz MA; Bedir R
Niger J Clin Pract; 2022 Mar; 25(3):315-324. PubMed ID: 35295055
[TBL] [Abstract][Full Text] [Related]
20. Intestinal metaplasia--its association with gastric cancer.
Malhotra V; Tatke M; Gondal R; Kumar N; Broor SL
Trop Gastroenterol; 1995; 16(4):22-6. PubMed ID: 8854951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
